In a couple of posts over the last few years I have stated that there is no way RVX could commercialize APB on their own as the costs were way to much for them to handle. As we can see Eversana has been accumulating a reasonable amount of costs to date and this is before a trial has even started. I would estimate that for full COVID, PAH and cardio the costs will come in between $500 million and $1 billion. This $10 million so far is just chicken feed.

Hang onto to your hats boys and girls.

tada